An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin.
about
Anticomplementary activity of Fusobacterium polymorphum in normal and C4-deficient sources of guinea pig complementFailure of cobra venom factor to prevent the generalized Shwartzman reaction and loss of renal cortical fibrinolytic activity.Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulationC1r deficiency: an inborn error associated with cutaneous and renal disease.Humoral bactericidal systems: nonspecific and specific mechanisms.Activation of the alternative complement pathway by L-phase variants of gram-positive bacteriaFatal anaphylaxis-like reaction induced by yeast mannans in nonsensitized mice.Escherichia coli bacteremia in the squirrel monkey. I. Effect of cobra venom factor treatmentOpsonin system of the group B streptococcus.Comparative Genomics Reveal That Host-Innate Immune Responses Influence the Clinical Prevalence of Legionella pneumophila Serogroups.A new complement-mediated cytolytic mechanism--the C1-bypass activation pathway.Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide.Complement-dependent release of immune complexes from the lymphocyte membrane.The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure.Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells.Activation of complement system by porins extracted from Salmonella typhimurium.Autosomal locus regulates inverse relationship between sialic acid content and capacity of mouse erythrocytes to activate human alternative complement pathway.Current knowledge and concepts of the relationship of malignancy, autoimmunity, and immunologic disease.Antibody-independent binding of the first component of complement (C1) and its subcomponent C1q to the S and R forms of Salmonella minnesotaFunction of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.Complement Aberrations in Serum from Children with Otitis Due to S. Pneumoniae or H. Influenzae
P2860
Q24561393-0B44C3D3-253E-44DA-83B4-8C18A92B9C63Q33464992-24FE953D-A82E-46A1-93B4-BBA570C5D553Q33465761-E7264C34-884E-4C5A-96E5-42D8EC7199D1Q34068956-D8B9B139-71DC-4B13-9275-0E9711667231Q34076763-A8B33A16-1033-4D4A-AEAF-390725A8EC2DQ34080073-44CB90A0-902D-4588-877E-4E47A7C054ACQ34468182-3137515C-D9E0-49C4-9F93-FE087AEFC863Q34499196-429DFD74-BD99-4542-B14F-1BCC0782918AQ34506335-8A4A95EE-E97F-42F7-AFBA-CE222690E2A2Q34796849-3F723D81-C50F-4AD5-95C3-AC67170DA1E9Q35097615-DBAF4B8F-9676-4243-9FBA-7CA479156C26Q36272438-A8B003EB-F975-4B29-AE28-2E4CFE065B66Q36272531-36140B35-5B82-43D6-88D6-B0F80D3B9E5CQ36362697-453B0A3E-D123-4CFC-BAE0-FA19FADE4D99Q36915180-354DDD2D-0BF1-43B3-9254-670B00667A86Q37042115-5C504CBE-DAC9-405B-9610-541AD2BB7896Q37596659-114B922C-41B6-4124-BB9D-C81918A7BF9CQ39870306-69683161-BCF7-4874-864F-2C8821042BE6Q40614455-B34F547B-9FB2-4A08-BF6C-0475C060171EQ40880870-82F13124-4D9F-45B4-A97C-4536EA83C00BQ58084243-C4151916-09EC-45CE-92FD-B1AA78D4D2A4
P2860
An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1971
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An alternate complement pathwa ...... serum; relation to properdin.
@en
An alternate complement pathwa ...... serum; relation to properdin.
@nl
type
label
An alternate complement pathwa ...... serum; relation to properdin.
@en
An alternate complement pathwa ...... serum; relation to properdin.
@nl
prefLabel
An alternate complement pathwa ...... serum; relation to properdin.
@en
An alternate complement pathwa ...... serum; relation to properdin.
@nl
P2093
P2860
P356
P1476
An alternate complement pathwa ...... serum; relation to properdin.
@en
P2093
P2860
P304
P356
10.1073/PNAS.68.6.1351
P407
P577
1971-06-01T00:00:00Z